NCT00198471

Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment

An Open-label Assessment of Intravitreous Injections of Vitrase (Hyaluronidase for Injection) for Inducing Posterior Vitreous Detachment in Subjects With Moderate to Severe Non-proliferative Diabetic Retinopathy

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 10 (planned)
• Sponsor: Bausch & Lomb Incorporated · Industry
• Sex: All
• Age: 50 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the efficacy of intravitreous injections of Vitrase to induce posterior vitreous detachment(PVD) in subjects with moderate to severe non-proliferative diabetic retinopathy.

Conditions

• Vitreous Detachment
• Diabetic Retinopathy

Interventions

Type	Name	Description
DRUG	Vitrase

Timeline

• Start date: 2005-07-01
• Primary completion: 2006-11-01
• Completion: 2006-11-01
• First posted: 2005-09-20
• Last updated: 2013-03-15

Locations

4 sites across 1 country: United States